Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lunai Bioworks Inc.RENB · Entity 7981 | Director | August 23, 2024 | August 27, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lunai Bioworks Inc.
Report date August 23, 2024 · Filed August 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 166,667 |
Reported balance
After 2024-08-23 transaction · row 1
1 source rowRow 1 · 2024-08-23 · Disposition to issuer · Disposed 833,333 · Balance 166,667 F1: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock. |
| Option to Purchase Shares of Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.69 · Expires 2034-08-23 | Direct | 978,261 |
Reported balance
After 2024-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-23 · Grant · Acquired 978,261 · Balance 978,261 F1: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock. F2: The option becomes exercisable in four equal installments on each three-month anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock.
F2: The option becomes exercisable in four equal installments on each three-month anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2024 Filed Aug 27, 2024 16:05 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to Purchase Shares of Common Stock · Derivative | 978,261 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001731122-24-001325 · ownership.xml · derivative · entry 2 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 978,261 Underlying: Common Stock · 978,261 shares Expires 2034-08-23 F1 · kind: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock. F2 · derivative.exercise_date: The option becomes exercisable in four equal installments on each three-month anniversary of the date of grant. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 16:05 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | Disposition to issuerCommon Stock | 833,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-24-001325 · ownership.xml · nonDerivative · entry 1 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,667 F1 · kind: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock. F1 · price: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock. Read SEC document |
| June 25, 2024 Filed Jul 1, 2024 08:40 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 18,634 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001731122-24-001048 · ownership.xml · derivative · entry 1 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,634 Underlying: Common stock · 18,634 shares Expires 2034-06-25 Read SEC document |
| October 23, 2023 Filed Nov 14, 2023 09:56 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 27,147 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001731122-23-002098 · ownership.xml · derivative · entry 2 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,147 Underlying: Common stock · 27,147 shares Expires 2033-10-11 Read SEC document |
| October 23, 2023 Filed Nov 14, 2023 09:56 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-23-002098 · ownership.xml · nonDerivative · entry 1 Miller Avram · CIK 0002000641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 F1 · date: On October 11, 2023, the Reporting Person entered into an Advisory Agreement, pursuant to which the Issuer agreed to issue Mr. Miller 1,000,000 shares of restricted stock, 166,667 of which will vest in 2024, 444,444 will vest in 2025, and 388,889 will vest in 2026, subject to Mr. Miller's continued service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.